Tata Steel Limited has informed the Exchange about Scheme of Amalgamation amongst Neelachal Ispat Nigam Limited and Tata Steel Limited and their respective shareholders

Nclt Scheme FiledListed Co AcquisitionStrategic Transactions View source PDF

TATASTEEL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.0%1-day move

₹195.20

prior close

₹196.40

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.1-1.3-1.1-1.2-2.0+0.6-4.2-2.0+0.8-1.8+5.6+8.6+7.6+2.7

Up moveDown movePending

AI summary

Tata Steel's board approved a Scheme of Amalgamation to merge its wholly owned subsidiary Neelachal Ispat Nigam Limited (NINL) into itself under Sections 230-232 of the Companies Act, 2013. NINL operates a 0.98 MTPA integrated steel plant in Kalinganagar, Odisha, and had negative net assets of ₹2,365.81 crore against revenue of ₹5,701.06 crore as on March 31, 2025. Since NINL is wholly owned, no new shares will be issued and Tata Steel's public shareholding pattern remains unchanged. Rationale cited is consolidation of long products assets, simplified group structure, and operational synergies. Separately, the board cleared a USD 2 billion (~₹18,488.10 crore) equity infusion into T Steel Holdings Pte. Ltd. (Singapore subsidiary) from FY2026-27 onwards to support overseas operations and debt repayment, and acquisition of the remaining 49% stake in Medica TS Hospital from Manipal for ₹1.49 crore to make it a wholly owned subsidiary.

Likely market impact

For existing shareholders, there is no change in shareholding or dilution since NINL is already wholly owned and the merger is purely a structural consolidation. The USD 2 billion overseas investment signals sizeable capital deployment from FY2026-27 that could pressure near-term cash flows but supports long-term overseas growth.